Stocks/Funds/CIK 2056786

Lunate Capital Ltd

concentrated
Quarterly 13F filings · Latest period 2026-03-31 · CIK 2056786
Assets
$120M
-29.7% YoY
Holdings
6
Lifetime alpha vs market
+0.12% annual
Average hold time
1.1 yr
median 1.3 yr

Quarterly history

Cum return +18% vs S&P +18% · α +0% lifetimeAUM $120M · peak $664MFlow $-160M (-60%)2025-032025-062025-092025-122026-03
AUM ($B)fundS&P 500(gap = α)/ Flow in/out

Behavior signals (lifetime)

Dip response
+0.00%
trims when stocks drop
when a holding falls −10%+
Middle response
+0.00%
baseline attrition
Rally response
-18.75%
trims into rallies
when a holding rises +10%+

Top positions · 6

Ticker$ value% portYoYHold time
RVMDRevolution Medicines, In$53M44.4%+175.0%1.3 yr
SAILSailPoint, Inc.$40M33.0%-29.4%1.3 yr
LINELineage, Inc.$20M16.3%-41.8%1.3 yr
NMRANeumora Therapeutics, In$4M3.4%+95.0%1.3 yr
NAVNNavan, Inc.$3M2.2%0.5 yr
$1M0.7%1.0 yr

Portfolio composition (YoY)

Industry mix
Biotechnology47.8%+1.2pp$58M
Software - Infrastructure33.0%+0.1pp$40M
REIT - Industrial16.3%-4.2pp$20M
Software - Application2.2%$3M
Unknown0.7%$1M
Country
US99.3%-0.7pp
Unknown0.7%
Top 5: 99.3% · Top 10: 100.0% · Top 25: 100.0%

Winners

TickerPrev $PnLYoY %
RVMD$78M+0.14B175.0%
NMRA$2M+0.00B95.0%
LINE$35M-0.01B-41.8%
SAIL$56M-0.02B-29.4%

Losers

TickerPrev $PnLYoY %
SAIL$56M-0.02B-29.4%
LINE$35M-0.01B-41.8%

Top buys this quarter · 0

No buys this quarter

Top sells this quarter · 1

RVMD Revolution Medicines, Inc.$160M

Quarterly history (TTM returns)

PeriodAUM# PosReturn (1yr)SPY (1yr)Alpha (1yr)Flow
2026-03-31$120M6+17.73%+17.59%+0.14%-0.16B
2025-12-31$264M6+9.60%+2.66%+6.94%-0.46B
2025-09-30$664M10-2.43%+8.12%-10.55%+0.49B
2025-06-30$178M6+3.83%+10.78%-6.95%+0.00B
2025-03-31$171M4